Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR5 | P32302 | 1/20 | 0.37 |
| ▸ | MYB | P10242 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2921948 | 0.88 | LMNA (0.31) | CXCR5MYBMAPTLMNANPSR1 | |
| SCHEMBL2919771 | 0.87 | MYB (0.31) | MYB | |
| SCHEMBL2921696 | 0.84 | HTR2A (0.38) | MAPTLMNAMEN1KMT2AKDM4E | |
| SCHEMBL2924154 | 0.84 | CXCR5 (0.36) | CXCR5 | |
| SCHEMBL2924942 | 0.84 | MYB (0.32) | MYBMEN1KMT2A | |
| SCHEMBL2917037 | 0.81 | — | — | |
| SCHEMBL2921361 | 0.81 | MGAM (0.34) | HTR2BGAA | |
| SCHEMBL2923357 | 0.81 | MYB (0.32) | MYBMEN1KMT2APTGS1PTGS2 | |
| SCHEMBL6191676 | 0.81 | CXCR5 (0.39) | CXCR5MAPTALDH1A1GAA | |
| SCHEMBL2923359 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1475383-B1 | TRANSITION METAL COMPLEXES, LIGANDS, POLYMERIZATION CATALYSTS FOR OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS | SUMITOMO CHEMICAL CO (JP) | 2010-09-08 | — | — | EP | disclosed |
| US-7241927-B2 | Transition metal complexes, ligands, catalysts for olefin polymerization, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-07-10 | — | — | US | disclosed |
| US-7141690-B2 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20060111525-A1 | Transition metal complexes, ligands, catalysts for olefin polymerization, and process for production of olefin polymers | HANAOKA HIDENORI | 2006-05-25 | — | — | US | disclosed |
| US-20050154158-A1 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-14 | — | — | US | disclosed |
| EP-1475383-A1 | TRANSITION METAL COMPLEXES, LIGANDS, POLYMERIZATION CATALYSTS FOR OLEFINS, AND PROCESS FOR PRODUCTION OF OLEFIN POLYMERS | Sumitomo Chemical Company, Limited (JP) | 2004-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154158-A1 | Transition metal complexes, ligands, polymerization catalysts for olefins, and process for production of olefin polymers | PYM1, OR10J3, AP1M1 | CXCR5 330/4885MYB 8/4885MAPT 3972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.